In young obese people without known cardiovascular disease, galectin-3 was related with preclinical metabolic heart disease and recommended as a screening tool for individuals with elevated risk for progression to obesity-related heart failure with preserved ejection fraction40. The gene discussed is LGALS3; the disease is obesity due to melanocortin 4 receptor deficiency.